Edition:
India

Centene Corp (CNC.N)

CNC.N on New York Stock Exchange

109.29USD
25 Apr 2018
Change (% chg)

$1.55 (+1.44%)
Prev Close
$107.74
Open
$107.88
Day's High
$109.97
Day's Low
$107.40
Volume
426,044
Avg. Vol
369,623
52-wk High
$113.73
52-wk Low
$71.33

Select another date:

Tue, Apr 24 2018

UPDATE 2-Centene cuts full-year forecast on Fidelis deal delay

April 24 Centene Corp on Tuesday cut its full-year forecast due to a delay in closing its $3.75 billion takeover of Fidelis Care, a not-for-profit Medicaid insurer, sending its shares down 3 percent in premarket trading.

Health insurer Centene's profit more than doubles

April 24 Centene Corp on Tuesday reported a quarterly profit that more than doubled as it added more members to its health insurance plans.

BRIEF-Centene Corp Reports 2018 Q1 Adj Earnings Per Share $2.17

* ORATION REPORTS 2018 FIRST QUARTER RESULTS AND ADJUSTS 2018 GUIDANCE

BRIEF-Centene Receives Regulatory Approval For Fidelis Care Transaction From New York Department Of Health And New York Department Of Financial Services

* CENTENE RECEIVES REGULATORY APPROVAL FOR THE FIDELIS CARE TRANSACTION FROM NEW YORK DEPARTMENT OF HEALTH AND NEW YORK DEPARTMENT OF FINANCIAL SERVICES Source text for Eikon: Further company coverage:

BRIEF-Centene Says Expects To Enter Undertakings With NY State Department. Of Health

* AS PART OF REGULATORY APPROVAL PROCESS FOR FIDELIS CARE DEAL, IT IS EXPECTED THAT CO WILL ENTER UNDERTAKINGS WITH NY STATE DEPARTMENT OF HEALTH

BRIEF-Centene Corp Files For Resale Of Up To 1.45 Mln Shares Of Co's Common Stock By The Selling Stockholder - SEC Filing

* CENTENE CORP FILES FOR RESALE OF UP TO 1.45 MILLION SHARES OF CO'S COMMON STOCK BY THE SELLING STOCKHOLDER - SEC FILING Source text: (http://bit.ly/2ImIkKz) Further company coverage:

BRIEF-Centene Makes Initial Investment In Pharmacy Benefit Manager, RxAdvance

* CENTENE AND RXADVANCE ESTABLISH TRANSFORMATIVE PARTNERSHIP TO CREATE NEXT GENERATION PHARMACY MANAGEMENT SOLUTION

BRIEF-Centene Corp CEO's 2017 Total Compensation Was $25.3 Mln

* CENTENE CORP CEO MICHAEL NEIDORFF'S 2017 TOTAL COMPENSATION WAS $25.3 MILLION VERSUS $22 MILLION IN 2016 – SEC FILING‍​ Source text (http://bit.ly/2DeQOPR) Further company coverage:

BRIEF-Centene To Acquire Community Medical Group To Expand Its Provider Assets

* CENTENE TO ACQUIRE COMMUNITY MEDICAL GROUP TO EXPAND ITS PROVIDER ASSETS

BRIEF-Centene To Buy MHM Services

* CENTENE TO ACQUIRE MHM SERVICES TO EXPAND NATIONAL FOOTPRINT IN CORRECTIONAL HEALTHCARE SECTOR

Select another date: